Chunru Shi
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Luteolin as a novel therapeutic for diabetic kidney disease: Targeting the ADAM10-TREM2 pathway.
Journal: Journal of advanced research
Published: July 18, 2025
Paeoniflorin Attenuates the Progression of Diabetic Kidney Disease by Regulating Macrophage Differentiation.
Journal: Phytotherapy research : PTR
Published: June 04, 2025
Direct pharmacological targeting of Piezo1 by Paeoniflorin: a novel therapeutic approach for renal fibrosis.
Journal: Journal of advanced research
Published: April 05, 2025
The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease.
Journal: Journal of ethnopharmacology
Published: March 18, 2024
Oleanolic acid inhibits mesangial cell proliferation and inflammatory response in mesangial proliferative glomerulonephritis through IL-17/ERK/AKT pathway.
Journal: International immunopharmacology
Published: February 09, 2024
Oleanolic acid and its analogues: promising therapeutics for kidney disease.
Journal: Chinese medicine
Published: January 13, 2024
New findings in preventing recurrence and improving renal function in AHUS patients after renal transplantation treated with eculizumab: a systemic review and meta-analyses.
Journal: Renal failure
Published: August 11, 2023
Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney.
Journal: Frontiers in pharmacology
Published: December 25, 2022
Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 21, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026